# Vonoprazan-based Therapy Versus Standard Regimen for Helicobacter Pylori Infection Management

> **NCT05614934** · PHASE4 · COMPLETED · sponsor: **Alexandria University** · enrollment: 132 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** standard Clarithromycin triple therapy
- **DRUG:** Vonoprazan triple therapy
- **DRUG:** Vonoprazan dual therapy

## Key facts

- **NCT ID:** NCT05614934
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-11
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-15
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05614934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05614934, "Vonoprazan-based Therapy Versus Standard Regimen for Helicobacter Pylori Infection Management". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05614934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*